Detalhe da pesquisa
1.
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.
Mol Ther
; 28(11): 2367-2378, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730744
2.
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer.
Cell Rep Med
; 5(2): 101397, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307029
3.
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration.
Clin Cancer Res
; 29(17): 3514-3525, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534996
4.
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1.
Sci Immunol
; 8(89): eadj5097, 2023 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976347
5.
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.
Cancer Immunol Res
; 10(7): 800-810, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507919
6.
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.
J Leukoc Biol
; 108(1): 363-376, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272502